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Alpha-thalassemia is a hereditary disease with a worldwide
distribution characterized by reduced or absent synthesis of
hemoglobin  chains. Deletions involving the  globin genes,
which are duplicated (2 and 1) and located in the  clus-
ter (16p13.3), are the most common causes of the disease and
account for over 80% of cases. Loss of a functional  gene in the
haploid genome results in +-thalassemia, which can occur in
a heterozygous (-/) or homozygous(-/-) state, while loss
of both  genes results in 0-thalassemia,which can also occur
in a heterozygous (–/)  or homozygous (–/–) state. A fifth -
thalassemic genotype is the result of the combination of both
the 0 and + alleles (-/–). While the first three genotypes
are associated with minimal hematological changes and the
fourth results in hemoglobin (Hb) Bart’s hydrops fetalis with
intrauterine or neonatal death, the double heterozygous 0/+
(-/–) state leads to Hb H disease. This latter is characterized
by unstable  chain tetramers (4), causing chronic, moderate
to severe hemolytic anemia with microcytosis, hypochromia,
jaundice and hepatosplenomegaly.1,2
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open  access article under the CC BY-NC-ND license (http://creativecomThere are seven deletions that usually affect populations
around the world: [-3.7, -4.2, -()20.5, –MED, –SEA, –FIL, –THAI].
The most common method used to screen for these deletions
is multiplex-gap polymerase chain reaction (PCR).3 When the
molecular basis of the disease cannot be identified in this way,
multiplex ligation-dependent probe amplification (MLPA) can
be used to detect new or rare deletions in the  genes, in the
whole cluster and in the -major regulatory element (MRE)
located 40 kb downstream of the  gene.1,2
We  describe the case of a Brazilian patient with Hb H dis-
ease caused by the combination of the -3.7 deletion, the most
common cause of -thalassemia in populations, and a rarer
0 deletion identified only by MPLA.
Case  report
This case study was part of a project approved by the Researchedical Sciences, Universidade Estadual de Campinas (Unicamp),
(Unicamp) under reference number 918/2007.
A 31-year-old white Brazilian male of Italian descent from
Araraquara, in the state of São Paulo, with a diagnosis of
 e Terapia Celular. Published by Elsevier Editora Ltda. This is an
mons.org/licenses/by-nc-nd/4.0/).
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Table 1 – Hematological data for the family studied.
Family member Proband Father Mother
RBC
(RV – M: 4.5–6.1; F: 4.2–5.4)
5.55  6.39 4.74
Hb
(RV – M: 14–18; F: 12–16)
9.2  13.8 12.5
Ht (%)
(RV – M: 41–52; F: 36–46)
16.6  44.0 38.6
MCV
(RV: 80–99)
61.6  81.4 68.9
MCH
(RV: 27–32)
16.6  21.6 26.4
RDW (%)
(RV: 10–15)
25.5  14.5 15.3
RC (%)
(RV: 0.5–2.5)
2.77  1.49 0.98
Hb pattern A2, A, H A2, A A2, A
Hb A2 (%)
(RV: 1.6–4)
1.5  2.70 2.40
Hb F (%)
(RV: <2)
0.5  0.20 0.20
Hb H (%) 4.0 - -
Heinz bodies/Hb H bodies Positive Negative Negative
 genotype -3.7/–MEDII –MEDII/ -3.7/
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mean corpuscular hemoglobin (pg); RDW: red cell distribution width 
ypochromic microcytic anemia was referred to our labora-
ory to investigate the cause of his anemia. Cell counts and
ematological indices were determined using an automated
ematology analyzer (Sysmex XE5000, Sysmex, Japan) and
emoglobin analysis was carried out by electrophoresis on
ellulose acetate in alkaline and neutral pHs and by cation-
xchange high-performance liquid chromatography (HPLC)
Variant IITM, Bio-Rad Laboratories, Hercules, CA, USA). In
ddition to the hemoglobin (Hb) A and Hb A2 fractions, an
b H fraction was detected accounting for 4% of the total Hb.
he patient’s parents were analyzed, and although they did
ot have any clinical complaints, both had minor hematologic
hanges similar to those found in -thalassemia.
The first molecular analysis consisted of multiplex-gap
CR,3 which showed a pattern in the patient’s sample observed
hen the 3.7 deletion is in a homozygous state, a result that
ould not explain the Hb H disease. The samples were then
nalyzed by MLPA  using the SALSA MLPA  P140 C1 HBA kit (MRC
olland, Holland),4 which analyzes approximately 360 kb of
NA extending from the 16p telomeric region to the DECR2
ene. The fragments were compared in Coffalyser.Net to iden-
ify possible changes in the number of copies of the  alleles.
In addition to the -3.7 deletion, MLPA  detected a large
eletion of approximately 30 kb affecting the , , 2, 1,
2 and 1 genes (Figure 1A). The extent of this deletion
nd the genes affected are compatible with two previously
escribed deletions: –DUTCH, described in individuals of Dutch
rigin,5 and –MEDII, described in individuals of Mediterranean
rigin.2,6 These can be distinguished from each other by a
pecific PCR protocol.5 Here, the patient’s DNA was first ampli-
ed with primers far from the deletion breakpoints, and
he product was re-amplified by nested PCR with primers
anking the breakpoints of both deletions. With the –MEDII(g/dL); Ht: hematocrit (%); MCV: mean corpuscular volume (fL); MCH:
C: reticulocyte count (%).
deletion, fragments of approximately 1.35 and 1.75 kb are
formed (Figure 1C), while with the –DUTCH deletion, the frag-
ments are 1.03 and 1.41 kb in size. Our results indicate that the
deletion in question consists of the –MEDII deletion (Figure 1B)
in combination with the -3.7 deletion (-3.7/–MEDII) in the
patient in combination with the normal allele (–MEDII/) in the
patient’s father. The patient’s mother was heterozygous for
the -3.7 deletion (-3.7/). The hematological and molecular
data for the family are shown in Table 1.
Discussion
Alpha-thalassemias are frequently caused by deletions. The
most common of these is the -3.7 deletion, which has a preva-
lence of 20–25% in Afro-Brazilians.7,8 Hb H disease is sporadic
in Brazil and is generally caused by a combination of the -3.7
deletion and –MEDI, –SEA or -()20.5 deletions.9 MLPA,  however,
has made it possible to detect rarer and even novel 0 dele-
tions and even those that only affect the regulatory element.
In the family analyzed here, Hb H disease was the result of a
combination of the -3.7 allele and –MEDII deletion, a genetic
alteration not previously reported in the Brazilian or Latin
American population. This deletion is larger than the –MEDI
(which is approximately 17 kb of DNA) and removes the zeta
gene in addition to the alpha genes. It has been found in
Mediterranean countries, such as Italy, Turkey, Greece and
Cyprus.6,10
Here, molecular analysis using MLPA, confirmed by familial
analysis, played an important role in the diagnosis. MLPA  has
made it possible to detect a wide range of mutations affect-
ing the globin genes in the Brazilian population that are not
detected by other techniques.
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Figure 1 – (A) Graph showing the result for the proband generated by the Coffalyser.Net software. The x-axis represents the
probes and the y-axis the ratio of the intensity of the proband sample to the mean intensity of reference samples. A ratio of
1 indicates the presence of both alleles, a ratio of 0.5 the loss of one allele and 0 the loss of that region in both alleles. (B)
Schematic representation of chromosome 16p13.3. The oval represents the telomeric region, the arrows show the locations
of the probes and the boxes the genes. The blue line corresponds to the deleted fragment, the dotted lines denote the first
and last deleted probe and the regions between the dotted and dashed lines show where the breakpoints may be (adapted
from MRC-Holland, 2014). (C) Agarose gel with the nested-PCR amplified product. The 1.75 kb and 1.35 kb bands correspond
to the –MEDII deletion.5 Sample 1 is the molecular weight marker (240 bp ladder); samples 2 and 3 are from the proband, and
samples 4 and 5 from his father.
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